drugset

drugset / Trial / NCT00307996

The Effect of CoQ10 Administration on Hemodialysis Patients

NCT00307996 ↗

Phase 4 Completed 40 enrolled University of Shizuoka

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.

Timeline

Start: 2004-03
Primary completion: —
Completion: 2004-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Coenzyme Q10	Other / unclassified	100 mg	—

Indications